Literature DB >> 28612836

Dyslipidaemia: ANGPTL3: a therapeutic target for atherosclerosis.

Gregory B Lim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28612836     DOI: 10.1038/nrcardio.2017.91

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.

Authors:  Mark J Graham; Richard G Lee; Teresa A Brandt; Li-Jung Tai; Wuxia Fu; Raechel Peralta; Rosie Yu; Eunju Hurh; Erika Paz; Bradley W McEvoy; Brenda F Baker; Nguyen C Pham; Andres Digenio; Steven G Hughes; Richard S Geary; Joseph L Witztum; Rosanne M Crooke; Sotirios Tsimikas
Journal:  N Engl J Med       Date:  2017-05-24       Impact factor: 91.245

2.  Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.

Authors:  Frederick E Dewey; Viktoria Gusarova; Richard L Dunbar; Colm O'Dushlaine; Claudia Schurmann; Omri Gottesman; Shane McCarthy; Cristopher V Van Hout; Shannon Bruse; Hayes M Dansky; Joseph B Leader; Michael F Murray; Marylyn D Ritchie; H Lester Kirchner; Lukas Habegger; Alex Lopez; John Penn; An Zhao; Weiping Shao; Neil Stahl; Andrew J Murphy; Sara Hamon; Aurelie Bouzelmat; Rick Zhang; Brad Shumel; Robert Pordy; Daniel Gipe; Gary A Herman; Wayne H H Sheu; I-Te Lee; Kae-Woei Liang; Xiuqing Guo; Jerome I Rotter; Yii-Der I Chen; William E Kraus; Svati H Shah; Scott Damrauer; Aeron Small; Daniel J Rader; Anders Berg Wulff; Børge G Nordestgaard; Anne Tybjærg-Hansen; Anita M van den Hoek; Hans M G Princen; David H Ledbetter; David J Carey; John D Overton; Jeffrey G Reid; William J Sasiela; Poulabi Banerjee; Alan R Shuldiner; Ingrid B Borecki; Tanya M Teslovich; George D Yancopoulos; Scott J Mellis; Jesper Gromada; Aris Baras
Journal:  N Engl J Med       Date:  2017-05-24       Impact factor: 91.245

  2 in total
  8 in total

1.  New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.

Authors:  Sean Paul Gaine; Renato Quispe; Jaideep Patel; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2022-06-25

2.  Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease.

Authors:  Gemma Cadby; Corey Giles; Phillip E Melton; Kevin Huynh; Natalie A Mellett; Thy Duong; Anh Nguyen; Michelle Cinel; Alex Smith; Gavriel Olshansky; Tingting Wang; Marta Brozynska; Mike Inouye; Nina S McCarthy; Amir Ariff; Joseph Hung; Jennie Hui; John Beilby; Marie-Pierre Dubé; Gerald F Watts; Sonia Shah; Naomi R Wray; Wei Ling Florence Lim; Pratishtha Chatterjee; Ian Martins; Simon M Laws; Tenielle Porter; Michael Vacher; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Kevin Taddei; Matthias Arnold; Gabi Kastenmüller; Kwangsik Nho; Andrew J Saykin; Xianlin Han; Rima Kaddurah-Daouk; Ralph N Martins; John Blangero; Peter J Meikle; Eric K Moses
Journal:  Nat Commun       Date:  2022-06-06       Impact factor: 17.694

Review 3.  RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.

Authors:  Nada Bejar; Trinh T Tat; Daniel L Kiss
Journal:  Curr Atheroscler Rep       Date:  2022-04-02       Impact factor: 5.967

4.  Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study.

Authors:  Xiaolu Jiao; Jiqiang He; Yunyun Yang; Song Yang; Juan Li; Yanwen Qin
Journal:  Cardiovasc Diabetol       Date:  2018-06-25       Impact factor: 9.951

5.  Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE-/- mice and inhibits the activation of CD4+ T cells.

Authors:  Liyu Zhou; Jun Long; Yuting Sun; Weikai Chen; Runze Qiu; Dongping Yuan
Journal:  Nutr Metab (Lond)       Date:  2020-05-27       Impact factor: 4.169

6.  Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity.

Authors:  Ting Sun; Wanlin Zhan; Lijiang Wei; Zuojun Xu; Li Fan; Yang Zhuo; Changqian Wang; Junfeng Zhang
Journal:  Lipids Health Dis       Date:  2021-11-06       Impact factor: 3.876

Review 7.  Targeting the vasculature in cardiometabolic disease.

Authors:  Nabil E Boutagy; Abhishek K Singh; William C Sessa
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

Review 8.  Roles of Reconstituted High-Density Lipoprotein Nanoparticles in Cardiovascular Disease: A New Paradigm for Drug Discovery.

Authors:  Jiansheng Huang; Dongdong Wang; Li-Hao Huang; Hui Huang
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.